CVR: 38546880
Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The company's owners include Novo Holdings A/S, Coöperatieve Gilde Healthcare IV U.A. and Danmarks Eksport- og Investeringsfond. Equity amounted to DKK 15,256,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at forske i, udvikle, producere og sælge bioteknologiske produkter og medicinalprodukter samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | - | 39.1 mio. | 15.3 mio. | 9 | |
| 2024 | - | - | 35 mio. | 27.6 mio. | 8 | |
| 2023 | - | -41.2 mio. | 36.2 mio. | 29.4 mio. | 10 | |
| 2022 | - | -39.9 mio. | 28.4 mio. | 18.6 mio. | 13 | |
| 2021 | - | -67 mio. | 67.9 mio. | 53.5 mio. | - | |
| 2020 | - | -60.6 mio. | 60.8 mio. | 54.2 mio. | - | |
| 2019 | -15.9 mio. | -15.2 mio. | 53.4 mio. | 52 mio. | 2 | |
| 2018 | -1.8 mio. | -2.1 mio. | 4.6 mio. | -1.8 mio. | 1 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 51500560, new email: [email protected], new website: www.draupnir.bio (July 14, 2026).
As of June 29, 2026, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
Draupnir Bio ApS has published its annual report for 2025.
Draupnir Bio ApS has published its annual report for 2024.
As of July 10, 2024, Novo Holdings A/S is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
As of July 10, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.
As of July 10, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
Draupnir Bio ApS has published its annual report for 2023. The net result was DKK -41,166,000.
As of March 26, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.
Draupnir Bio ApS has published its annual report for 2022. The net result was DKK -39,890,000.
Draupnir Bio ApS has published its annual report for 2021. The net result was DKK -67,044,000.
As of February 24, 2022, Ivan Burkov has joined the board of directors of Draupnir Bio ApS.
As of February 24, 2022, Roel Bulthuis has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2020. The net result was DKK -60,620,000.
As of June 9, 2021, Emmanuelle Coutanceau has joined the board of directors of Draupnir Bio ApS.
As of June 9, 2021, Eva-Lotta Coulter has joined the board of directors of Draupnir Bio ApS.
As of June 8, 2021, Emmanuelle Coutanceau has left the board of directors of Draupnir Bio ApS.
As of June 1, 2021, Andrew Thomas Hotchkiss is registered as director of Draupnir Bio ApS.
As of June 1, 2021, Simon Glerup Pedersen has stepped down as director of Draupnir Bio ApS.
As of September 3, 2020, Robert Andrew Donald Scott has joined the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2019. Gross profit came to DKK -15,909,546, and the net result was DKK -15,194,060.
As of May 25, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Draupnir Bio ApS.
As of May 25, 2020, A/S PSE 17 NR. 1056 has stepped down as auditor of Draupnir Bio ApS.
As of April 30, 2020, Roel Bulthuis has joined the board of directors of Draupnir Bio ApS.
As of April 30, 2020, Fiona MacLaughlin has left the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Simon Glerup Pedersen has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Fiona MacLaughlin has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Stefan Emanuel Luzi has joined the board of directors of Draupnir Bio ApS.
As of October 23, 2019, Peter Hans Andreas Seeberger has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its annual report for 2018. Gross profit came to DKK -1,779,479, and the net result was DKK -2,117,554.
As of October 26, 2018, Emmanuelle Coutanceau has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peter Hans Andreas Seeberger has joined the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Camilla Gustafsen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Simon Glerup Pedersen has left the board of directors of Draupnir Bio ApS.
As of October 26, 2018, Peder Søndergaard Madsen has left the board of directors of Draupnir Bio ApS.
Draupnir Bio ApS has published its interim report for the period April 4, 2017 – December 31, 2017.
As of April 4, 2017, A/S PSE 17 NR. 1056 has been appointed auditor of Draupnir Bio ApS.
As of April 4, 2017, Camilla Gustafsen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Simon Glerup Pedersen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Peder Søndergaard Madsen has joined the board of directors of Draupnir Bio ApS.
As of April 4, 2017, Simon Glerup Pedersen is registered as director of Draupnir Bio ApS.
Draupnir Bio ApS was founded on April 4, 2017.
Companies in the same industry and area
CVR 40766383
CVR 46613139
CVR 34688605
CVR 44504332
CVR 43917897
companydata.dk